文献速递眼整形与眼眶

基于智能手机的三维眼部重建用于自动化定量上睑下垂评估

Smartphone-Based 3D Ocular Reconstruction for Automated Quantitative Blepharoptosis Evaluation.
PubMed 文献 · JAMA Ophthalmol · 2026-09-24

这项前瞻性诊断/预后研究在5家医院纳入952名3岁及以上参与者,用10秒智能手机视频进行三维重建,自动测量MRD1和提上睑肌功能并与专家评估对照。DRP与专家测量一致性高,诊断上睑下垂AUC为0.97,识别手术方式AUC为0.98,术后3个月复发率为7.3%。

要点

  • DRP与专家测量MRD1的MAE为0.52 mm,LF的MAE为0.95 mm。
  • 诊断上睑下垂AUC 0.97,识别手术方式AUC 0.98。
  • 206名手术参与者248眼术后3个月复发率7.3%。

核心结论

  • 商用智能手机可能支持准确、标准化的上睑下垂定量评估,展现用于外眼评估和临床决策的潜力,但需进一步研究评估其临床影响。

研究设计与样本

  • 前瞻性诊断/预后研究,2025年在5家医院开展,纳入3岁及以上参与者,以同日眼整形专家评估为参考标准。
  • 共952名参与者1904眼,平均年龄27.9岁(范围3-86岁),女性493名(51.8%),男性459名(48.2%)。
  • 质控后1862眼纳入MRD1分析,1830眼纳入LF分析;手术参与者术后3个月重复专家测量以评估复发。
  • DRP使用10秒智能手机视频进行三维重建,包含公制单位转换和实时质量控制。

主要发现

  • DRP与专家测量MRD1的MAE为0.52 mm(95% CI,0.50-0.54 mm),LF的MAE为0.95 mm(95% CI,0.91-0.98 mm)。
  • 诊断上睑下垂的AUC为0.97(95% CI,0.96-0.97)。
  • 识别手术方式的AUC为0.98(95% CI,0.97-0.98)。
  • 性能在性别、年龄和地理区域间保持一致。
  • 206名手术参与者248眼术后3个月复发率为7.3%(95% CI,4.4%-11.2%;18/248眼),处于既往报告率的较低范围。

关键数值与推荐

  • MRD1测量一致性:MAE 0.52 mm(95% CI,0.50-0.54 mm)。
  • LF测量一致性:MAE 0.95 mm(95% CI,0.91-0.98 mm)。
  • 上睑下垂诊断性能:AUC 0.97(95% CI,0.96-0.97)。
  • 手术方式识别性能:AUC 0.98(95% CI,0.97-0.98)。
  • 术后3个月复发率:7.3%(95% CI,4.4%-11.2%;18/248眼)。

临床怎么用

  • 可考虑用智能手机10秒视频三维重建辅助上睑下垂的定量外眼评估,包括MRD1和LF测量及临床分类。
  • DRP结果与专家测量一致性高,或可辅助上睑下垂诊断和手术方式选择,但临床影响尚待进一步研究。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: External ocular examination is central to ptosis evaluation, yet it often relies on manual, experience-dependent measurements with variable accuracy and reproducibility. OBJECTIVE: To develop and prospectively evaluate the Digital Rulers of Ptosis (DRP), a smartphone-based 3-dimensional (3D) reconstruction system for automated quantitative external ocular assessment in blepharoptosis, including marginal reflex distance 1 (MRD1) and levator muscle function (LF), and clinical classification. DESIGN, SETTING, AND PARTICIPANTS: This diagnostic/prognostic study was conducted prospectively across 5 hospitals in 2025. Participants 3 years and older underwent smartphone video capture and same-day oculoplastic specialist assessment as the reference standard. Participants undergoing surgery received repeat specialist measurements of MRD1 and LF at 3 months postoperatively to assess recurrence. EXPOSURE: DRP uses a 10-second smartphone video for 3D reconstruction with metric unit conversion and real-time quality control. MAIN OUTCOMES AND MEASURES: Agreement between DRP and specialist measurements was assessed by mean absolute error (MAE) and intraclass correlation coefficient. Diagnostic performance was assessed by area under the receiver operating characteristic curve (AUC), sensitivity, specificity, positive predictive value, negative predictive value. For patients who underwent surgery, 3-month postoperative recurrence was assessed. RESULTS: Among 952 participants (1904 eyes), the mean age was 27.9 years (range, 3-86 years); 493 participants were female (51.8%) and 459 were male (48.2%). A total of 1862 eyes were included in MRD1 analysis and 1830 eyes in LF analysis after quality control. DRP demonstrated high agreement with specialist measurements for MRD1 (MAE, 0.52 mm; 95% CI, 0.50-0.54 mm) and LF (MAE, 0.95 mm; 95% CI, 0.91-0.98 mm). For diagnosing ptosis, DRP achieved an AUC of 0.97 (95% CI, 0.96-0.97). For identifying surgical approach, DRP achieved an AUC of 0.98 (95% CI, 0.97-0.98). Performance remained consistent across sex, age, and geographic region. Among 206 surgical participants (248 eyes), the 3-month postoperative recurrence rate was 7.3% (95% CI, 4.4%-11.2%; 18/248 eyes), within the lower range of previously reported rates. CONCLUSIONS AND RELEVANCE: This study found that accurate, standardized quantitative blepharoptosis assessment might be supported by commercially available smartphones, demonstrating the potential of smartphone-based 3D reconstruction for external ocular assessment and clinical decision-making. Further studies are needed to evaluate its clinical impact.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Yang Y, Han Y, Wang R, et al. Smartphone-Based 3D Ocular Reconstruction for Automated Quantitative Blepharoptosis Evaluation. JAMA Ophthalmol. 2026. PMID: 42783353. doi:10.1001/jamaophthalmol.2026.4120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。